{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:37:33Z","timestamp":1768927053215,"version":"3.49.0"},"reference-count":43,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2019]]},"DOI":"10.1620\/tjem.247.59","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T22:39:11Z","timestamp":1548369551000},"page":"59-67","source":"Crossref","is-referenced-by-count":18,"title":["La-Related Protein 4 as a Suppressor for Motility of Ovarian Cancer Cells"],"prefix":"10.1620","volume":"247","author":[{"given":"Mahy","family":"Egiz","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University"},{"name":"Department of Obstetrics and Gynecology, Menoufia University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masumi","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuewei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Shigeta","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Toyoshima","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Kitatani","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University"},{"name":"Tohoku Medical Megabank Organization, Tohoku University"},{"name":"Laboratory of Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Graduate School of Medicine, Tohoku University"},{"name":"Tohoku Medical Megabank Organization, Tohoku University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Bai, H., Li, H., Li, W., Gui, T., Yang, J., Cao, D. &amp; Shen, K. (2015)  The PI3K\/AKT\/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.  <i>Oncotarget<\/i>, 6, 25520-25532.","DOI":"10.18632\/oncotarget.4550"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bayfield, M.A., Yang, R. &amp; Maraia, R.J. (2010)  Conserved and divergent features of the structure and function of La and La-related proteins (LARPs).  <i>Biochim. Biophys. Acta<\/i>, 1799, 365-378.","DOI":"10.1016\/j.bbagrm.2010.01.011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bisi, S., Disanza, A., Malinverno, C., Frittoli, E., Palamidessi, A. &amp; Scita, G. (2013)  Membrane and actin dynamics interplay at lamellipodia leading edge.  <i>Curr. Opin. Cell Biol<\/i>., 25, 565-573.","DOI":"10.1016\/j.ceb.2013.04.001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Burrows, C., Abd Latip, N., Lam, S.J., Carpenter, L., Sawicka, K., Tzolovsky, G., Gabra, H., Bushell, M., Glover, D.M., Willis, A.E. &amp; Blagden, S.P. (2010)  The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration.  <i>Nucleic Acids Res<\/i>., 38, 5542-5553.","DOI":"10.1093\/nar\/gkq294"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chen, S., Wang, J., Gou, W.F., Xiu, Y.L., Zheng, H.C., Zong, Z.H., Takano, Y. &amp; Zhao, Y. (2013)  The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma.  <i>Int. J. Mol. Sci<\/i>., 14, 24187-24199.","DOI":"10.3390\/ijms141224187"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Jin, Z., Agarwal, R., Ma, K., Yang, J., Ibrahim, S., Olaru, A.V., David, S., Ashktorab, H., Smoot, D.T., Duncan, M.D., Hutcheon, D.F., Abraham, J.M., Meltzer, S.J. &amp; Mori, Y. (2012)  LARP7 is a potential tumor suppressor gene in gastric cancer.  <i>Lab. Invest<\/i>., 92, 1013-1019.","DOI":"10.1038\/labinvest.2012.59"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Dhillon, A.S., Hagan, S., Rath, O. &amp; Kolch, W. (2007)  MAP kinase signalling pathways in cancer.  <i>Oncogene<\/i>, 26, 3279-3290.","DOI":"10.1038\/sj.onc.1210421"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Faried, A., Faried, L.S., Usman, N., Kato, H. &amp; Kuwano, H. (2007)  Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.  <i>Ann. Surg. Oncol<\/i>., 14, 3593-3601.","DOI":"10.1245\/s10434-007-9562-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Fritz, G., Brachetti, C., Bahlmann, F., Schmidt, M. &amp; Kaina, B. (2002)  Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters.  <i>Br. J. Cancer<\/i>, 87, 635-644.","DOI":"10.1038\/sj.bjc.6600510"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Glisovic, T., Bachorik, J.L., Yong, J. &amp; Dreyfuss, G. (2008)  RNA-binding proteins and post-transcriptional gene regulation.  <i>FEBS Lett<\/i>., 582, 1977-1986.","DOI":"10.1016\/j.febslet.2008.03.004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Guan, X. (2015)  Cancer metastases: challenges and opportunities.  <i>Acta Pharm. Sin. B<\/i>, 5, 402-418.","DOI":"10.1016\/j.apsb.2015.07.005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Gyorffy, B., Lanczky, A. &amp; Szallasi, Z. (2012)  Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.  <i>Endocr. Relat. Cancer<\/i>, 19, 197-208.","DOI":"10.1530\/ERC-11-0329"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A. &amp; Sarkar, S. (2015)  EMT and tumor metastasis.  <i>Clin. Transl. Med<\/i>., 4, 6.","DOI":"10.1186\/s40169-015-0048-3"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Hopkins, T.G., Mura, M., Al-Ashtal, H.A., Lahr, R.M., Abd-Latip, N., Sweeney, K., Lu, H., Weir, J., El-Bahrawy, M., Steel, J.H., Ghaem-Maghami, S., Aboagye, E.O., Berman, A.J. &amp; Blagden, S.P. (2016)  The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.  <i>Nucleic Acids Res<\/i>., 44, 1227-1246.","DOI":"10.1093\/nar\/gkv1515"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Horiuchi, A., Imai, T., Wang, C., Ohira, S., Feng, Y., Nikaido, T. &amp; Konishi, I. (2003)  Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.  <i>Lab. Invest<\/i>., 83, 861-870.","DOI":"10.1097\/01.LAB.0000073128.16098.31"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Horiuchi, A., Kikuchi, N., Osada, R., Wang, C., Hayashi, A., Nikaido, T. &amp; Konishi, I. (2008)  Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer.  <i>Cancer Sci<\/i>., 99, 2532-2539.","DOI":"10.1111\/j.1349-7006.2008.00977.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Hwang, Y.S., Hodge, J.C., Sivapurapu, N. &amp; Lindholm, P.F. (2006)  Lysophosphatidic acid stimulates PC-3 prostate cancer cell Matrigel invasion through activation of RhoA and NF-kappaB activity.  <i>Mol. Carcinog<\/i>., 45, 518-529.","DOI":"10.1002\/mc.20183"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Jelovac, D. &amp; Armstrong, D.K. (2011)  Recent progress in the diagnosis and treatment of ovarian cancer.  <i>CA Cancer J. Clin<\/i>., 61, 183-203.","DOI":"10.3322\/caac.20113"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Kamai, T., Yamanishi, T., Shirataki, H., Takagi, K., Asami, H., Ito, Y. &amp; Yoshida, K. (2004)  Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer.  <i>Clin. Cancer Res<\/i>., 10, 4799-4805.","DOI":"10.1158\/1078-0432.CCR-0436-03"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Kitatani, K., Usui, T., Sriraman, S.K., Toyoshima, M., Ishibashi, M., Shigeta, S., Nagase, S., Sakamoto, M., Ogiso, H., Okazaki, T., Hannun, Y.A., Torchilin, V.P. &amp; Yaegashi, N. (2016)  Ceramide limits phosphatidylinositol-3-kinase C2beta-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid.  <i>Oncogene<\/i>, 35, 2801-2812.","DOI":"10.1038\/onc.2015.330"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Krause, M. &amp; Gautreau, A. (2014)  Steering cell migration: lamellipodium dynamics and the regulation of directional persistence.  <i>Nat. Rev. Mol. Cell Biol<\/i>., 15, 577-590.","DOI":"10.1038\/nrm3861"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Lee, Y.K. &amp; Park, N.H. (2009)  Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers.  <i>Gynecol. Oncol<\/i>., 112, 475-480.","DOI":"10.1016\/j.ygyno.2008.11.031"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Liao, B., Hu, Y. &amp; Brewer, G. (2007)  Competitive binding of AUF1 and TIAR to MYC mRNA controls its translation.  <i>Nat. Struct. Mol. Biol<\/i>., 14, 511-518.","DOI":"10.1038\/nsmb1249"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Machesky, L.M. (2008)  Lamellipodia and filopodia in metastasis and invasion.  <i>FEBS Lett<\/i>., 582, 2102-2111.","DOI":"10.1016\/j.febslet.2008.03.039"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Matsuoka, T. &amp; Yashiro, M. (2014)  Rho\/ROCK signaling in motility and metastasis of gastric cancer.  <i>World J. Gastroenterol<\/i>., 20, 13756-13766.","DOI":"10.3748\/wjg.v20.i38.13756"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Mura, M., Hopkins, T.G., Michael, T., Abd-Latip, N., Weir, J., Aboagye, E., Mauri, F., Jameson, C., Sturge, J., Gabra, H., Bushell, M., Willis, A.E., Curry, E. &amp; Blagden, S.P. (2015)  LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression.  <i>Oncogene<\/i>, 34, 5025-5036.","DOI":"10.1038\/onc.2014.428"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Naora, H. &amp; Montell, D.J. (2005)  Ovarian cancer metastasis: integrating insights from disparate model organisms.  <i>Nat. Rev. Cancer<\/i>, 5, 355-366.","DOI":"10.1038\/nrc1611"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Parsons, J.T., Horwitz, A.R. &amp; Schwartz, M.A. (2010)  Cell adhesion: integrating cytoskeletal dynamics and cellular tension.  <i>Nat. Rev. Mol. Cell Biol<\/i>., 11, 633-643.","DOI":"10.1038\/nrm2957"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Pille, J.Y., Denoyelle, C., Varet, J., Bertrand, J.R., Soria, J., Opolon, P., Lu, H., Pritchard, L.L., Vannier, J.P., Malvy, C., Soria, C. &amp; Li, H. (2005)  Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.  <i>Mol. Ther<\/i>., 11, 267-274.","DOI":"10.1016\/j.ymthe.2004.08.029"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Raineri, I., Wegmueller, D., Gross, B., Certa, U. &amp; Moroni, C. (2004)  Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference.  <i>Nucleic Acids Res<\/i>., 32, 1279-1288.","DOI":"10.1093\/nar\/gkh282"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Rajkowitsch, L., Chen, D., Stampfl, S., Semrad, K., Waldsich, C., Mayer, O., Jantsch, M.F., Konrat, R., Blasi, U. &amp; Schroeder, R. (2007)  RNA chaperones, RNA annealers and RNA helicases.  <i>RNA Biol<\/i>., 4, 118-130.","DOI":"10.4161\/rna.4.3.5445"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Ridley, A.J. (2015)  Rho GTPase signalling in cell migration.  <i>Curr. Opin. Cell Biol<\/i>., 36, 103-112.","DOI":"10.1016\/j.ceb.2015.08.005"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Schmitz, A.A., Govek, E.E., Bottner, B. &amp; Van Aelst, L. (2000)  Rho GTPases: signaling, migration, and invasion.  <i>Exp. Cell Res<\/i>., 261, 1-12.","DOI":"10.1006\/excr.2000.5049"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Seetharaman, S., Flemyng, E., Shen, J., Conte, M.R. &amp; Ridley, A.J. (2016)  The RNA-binding protein LARP4 regulates cancer cell migration and invasion.  <i>Cytoskeleton<\/i> (<i>Hoboken<\/i>), 73, 680-690.","DOI":"10.1002\/cm.21336"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Somlyo, A.V., Bradshaw, D., Ramos, S., Murphy, C., Myers, C.E. &amp; Somlyo, A.P. (2000)  Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells.  <i>Biochem. Biophys. Res. Commun<\/i>., 269, 652-659.","DOI":"10.1006\/bbrc.2000.2343"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Sommer, G., Dittmann, J., Kuehnert, J., Reumann, K., Schwartz, P.E., Will, H., Coulter, B.L., Smith, M.T. &amp; Heise, T. (2011a)  The RNA-binding protein La contributes to cell proliferation and CCND1 expression.  <i>Oncogene<\/i>, 30, 434-444.","DOI":"10.1038\/onc.2010.425"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Sommer, G., Rossa, C., Chi, A.C., Neville, B.W. &amp; Heise, T. (2011b)  Implication of RNA-binding protein La in proliferation, migration and invasion of lymph node-metastasized hypopharyngeal SCC cells.  <i>PLoS One<\/i>, 6, e25402.","DOI":"10.1371\/journal.pone.0025402"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Vignjevic, D. &amp; Montagnac, G. (2008)  Reorganisation of the dendritic actin network during cancer cell migration and invasion.  <i>Semin. Cancer Biol<\/i>., 18, 12-22.","DOI":"10.1016\/j.semcancer.2007.08.001"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Wang, X., Jiang, W., Kang, J., Liu, Q. &amp; Nie, M. (2015)  Knockdown of RhoA expression alters ovarian cancer biological behavior in vitro and in nude mice.  <i>Oncol. Rep<\/i>., 34, 891-899.","DOI":"10.3892\/or.2015.4009"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Ye, L., Lin, S.T., Mi, Y.S., Liu, Y., Ma, Y., Sun, H.M., Peng, Z.H. &amp; Fan, J.W. (2016)  Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.  <i>Tumour Biol<\/i>., 37, 14585-14594.","DOI":"10.1007\/s13277-016-5332-3"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Yeung, T.L., Leung, C.S., Yip, K.P., Au Yeung, C.L., Wong, S.T. &amp; Mok, S.C. (2015)  Cellular and molecular processes in ovarian cancer metastasis.  A review in the theme: cell and molecular processes in cancer metastasis.  <i>Am. J. Physiol. Cell Physiol<\/i>., 309, C444-456.","DOI":"10.1152\/ajpcell.00188.2015"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Zhang, X., Kitatani, K., Toyoshima, M., Ishibashi, M., Usui, T., Minato, J., Egiz, M., Shigeta, S., Fox, T., Deering, T., Kester, M. &amp; Yaegashi, N. (2018)  Ceramide nanoliposomes as a MLKL-dependent, necroptosis-inducing, chemotherapeutic reagent in ovarian cancer.  <i>Mol. Cancer Ther<\/i>., 17, 50-59.","DOI":"10.1158\/1535-7163.MCT-17-0173"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Tian, Y., Du, J., Hu, Z., Yang, L., Liu, J. &amp; Gu, L. (2012)  Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration.  <i>PLoS One<\/i>, 7, e37823.","DOI":"10.1371\/journal.pone.0037823"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/247\/1\/247_59\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T02:41:47Z","timestamp":1548556907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/247\/1\/247_59\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.247.59","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}